Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan.
Anticancer Res. 2020 Jan;40(1):293-298. doi: 10.21873/anticanres.13952.
BACKGROUND/AIM: The prognosis of pancreatic cancer remains poor with a high incidence of recurrence even after curative resection. The aim of this study was to investigate prognostic factors in patients with recurrent pancreatic cancer using the multicenter database.
The subjects were 196 patients with recurrent pancreatic cancer who underwent resection between 2008 and 2015. We retrospectively investigated the relation between clinicopathological characteristics of the patients and overall survival from recurrence using univariate and multivariate analyses.
In univariate analysis, the positive lymphatic invasion (p=0.0240), time to recurrence from resection <1 year (p<0.0001), sites of recurrence except for local or lymph node (p=0.0273), liver recurrence (p=0.0389) and peritoneal recurrence (p<0.0001) were significantly associated with poor overall survival from recurrence. In multivariate analysis, time to recurrence from resection <1 year (p<0.0001) and peritoneal recurrence (p<0.0001) were independently associated with poor overall survival from recurrence.
Time to recurrence from resection <1 year and peritoneal recurrence were significant independent predictors of poor overall survival from recurrence in patients with recurrent pancreatic cancer.
背景/目的:即使在根治性切除术后,胰腺癌的预后仍然很差,复发率很高。本研究的目的是使用多中心数据库研究复发性胰腺癌患者的预后因素。
本研究回顾性分析了 2008 年至 2015 年间接受切除术的 196 例复发性胰腺癌患者的临床病理特征与复发后总生存期之间的关系。采用单因素和多因素分析。
单因素分析显示,阳性淋巴管浸润(p=0.0240)、从切除到复发的时间<1 年(p<0.0001)、除局部或淋巴结外的复发部位(p=0.0273)、肝复发(p=0.0389)和腹膜复发(p<0.0001)与复发后总生存期不良显著相关。多因素分析显示,从切除到复发的时间<1 年(p<0.0001)和腹膜复发(p<0.0001)与复发后总生存期不良独立相关。
从切除到复发的时间<1 年和腹膜复发是复发性胰腺癌患者复发后总生存期不良的显著独立预测因素。